Clinical trial
Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human…
NCT00389207 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00389207 |
|---|---|
| Title | Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive Adults |
| Official title | Randomized, Open Label Study Evaluating the Lipid Profile Difference and Efficacy of a Combined Therapy Including Tenofovir, Emtricitabine + Atazanavir / r or NVP in Naive HIV - 1 Infected Patients. |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | nevirapine bid, nevirapine qd, atazanavir |
| Enrollment | 576 |
| Start date | Oct 1, 2006 |
| Primary completion | Feb 1, 2011 |
| First posted | Oct 18, 2006 |
| Last update posted | Jan 27, 2014 |
| Countries | Argentina, Germany, Italy, Mexico, Poland, Portugal, Romania, Spain, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: